Why BMI Thresholds Are Lower for South Asian, Chinese & Black UK Patients (2026)

The standard BMI categories — healthy weight 18.5–24.9, overweight 25–29.9, obese 30+ — were derived from data on White European populations in the 1980s and 1990s. They do not apply equally to everyone.

For South Asian, Chinese, Black African and Caribbean adults, the same cardiometabolic risk (type 2 diabetes, hypertension, heart disease) occurs at a lower BMI. NICE PH46 (2013) and the WHO expert consultation (2004) both recommend lower BMI thresholds for these groups. In practice, that shifts the entire weight-management eligibility ladder down by about 2.5 BMI units.

Why the cut-offs are lower

At a given BMI, South Asian and East Asian populations carry more visceral fat and less lean mass than White Europeans. Visceral fat is metabolically active and drives insulin resistance, dyslipidaemia and hypertension far more than subcutaneous fat. The result: South Asian adults at BMI 23 have similar diabetes risk to White European adults at BMI 25; at BMI 27.5 they have similar risk to a White European adult at BMI 30.

The WHO expert consultation in 2004 concluded:

"The proportion of Asian people with a high risk of type 2 diabetes and cardiovascular disease is substantial at BMIs lower than the existing WHO cut-off point for overweight (≥25 kg/m²)."

NICE adopted the same logic for the UK in 2013 (PH46), naming South Asian, Chinese, other Asian, Black African, Black Caribbean and Mixed ethnic groups. The evidence base is strongest for South Asian and Chinese populations; risk patterns for Black African and Caribbean populations are more heterogeneous but the lower cut-off remains recommended in routine practice.

The full adjusted scale

What this means for Mounjaro and Wegovy eligibility

NICE TA1026 (Mounjaro) and TA875 (Wegovy) cite BMI thresholds for NHS prescribing. The ethnicity adjustment applies:

• Private GLP-1 prescribing. Most private providers in the UK apply the lower thresholds for clinical-risk reasons. A 35-year-old British Pakistani man at BMI 28 is in Obese Class I on the adjusted scale and likely qualifies for Mounjaro or Wegovy via private prescription, even though he would be classified as Overweight on the standard scale.

• NHS Tier 3 specialist weight management services. These services apply the lower cut-offs when assessing referral eligibility. The standard NHS Tier 3 entry point is BMI ≥35 with a weight-related comorbidity; for adjusted populations, the equivalent is BMI ≥32.5.

• NHS Tier 4 (bariatric surgery). Standard threshold BMI ≥40 (or ≥35 with comorbidity); adjusted threshold ≥37.5 (or ≥32.5 with comorbidity).

• Mounjaro on the NHS. NICE TA1026 cites the same eligibility ladder; the ethnicity adjustment moves you up the ladder at lower BMI.

What to do if you're in one of these groups

1. Ask your GP to apply the NICE PH46 adjustment. If you're South Asian, Chinese, Black African, Caribbean or Mixed background, ask explicitly: "Can you assess my eligibility using the adjusted BMI thresholds in NICE PH46?" Many GPs will, but the standard thresholds are still the default in some practices.

2. Use the calculator on TreatCompare with the ethnicity option set. The BMI & eligibility checker on /weight-loss shifts the cut-offs when you select "South Asian, Chinese, Black African or Caribbean" so you see the adjusted classification immediately.

3. Don't wait until you cross the standard 30 threshold. The whole point of the adjustment is that cardiometabolic harm is already happening at BMI 27.5 in these groups. Earlier intervention — diet, activity, GLP-1 medication if appropriate — is the clinical case.

Australia, the US and other markets

The principle of ethnicity-adjusted BMI thresholds is internationally accepted, with slightly different framings:

• Australia. RACGP and NHMRC obesity management guidance follows the WHO Asian-specific cut-offs. The same 2.5-point downward shift applies to South Asian, Chinese, Pacific Islander and Aboriginal & Torres Strait Islander populations.
• United States. The American Diabetes Association uses BMI ≥23 as the type 2 diabetes screening threshold for Asian-American adults (vs ≥25 for the general population). Endocrine Society and AACE guidelines reference similar cut-offs.
• Canada. Canadian Adult Obesity Clinical Practice Guidelines cite the same ethnicity adjustments.

Limitations and caveats

• BMI is a population-level screening tool, not a diagnostic test. It does not measure body composition. A muscular adult of any ethnicity can have a high BMI without elevated cardiometabolic risk. A sedentary thin adult can have high visceral fat without crossing any BMI threshold ("thin outside, fat inside").
• Mixed ethnic backgrounds vary. The lower threshold typically applies if one parent is from a higher-risk group, but individual risk also depends on family history, fitness, diet and lifestyle. Speak to a clinician about your specific risk picture.
• The adjusted cut-offs are guidance, not law. Different prescribers and commissioning bodies apply them with varying strictness. The NHS standard is to apply them; private prescribers are more variable.
• This is not personalised medical advice. Final eligibility depends on a clinician's assessment of your full medical history.